Comparing the Clinical and Functinal Outcomes of Treating the Elbow Lateral Epicondylitis (Tennis Elbow) with Dry Needling and Corticosteroid Injection

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015082523750N1

Enrollment

100

Registered

2016-06-08

Start date

2014-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elbow Lateral Epicondylitis (Tennis Elbow). Lateral epicondylitis

Interventions

Intervention 1: Intervention: dry needling Intervention methods: 1- initially determine the exact location of tenderness in Arjun extensor tendon by examination 2- Local anesthesia by lidocaine 3- Pie

Treatment - Surgery

Intervention: dry needling Intervention methods: 1- initially determine the exact location of tenderness in Arjun extensor tendon by examination 2- Local anesthesia by lidocaine 3- Piercing the Damag

control: Corticosteroid Intervention methods: 1- initially determine the exact location of tenderness in Arjun extensor tendon by examination 2- Local anesthesia by lidocaine 3- prednisolone 40mg in

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Report of pressure pain in humeral epicondyle; Increased pain during extension of wrist In the face of resistance And mid-finger test positive Exclusion criteria: Treatment of pain in the past two weeks with sedation, NSAID or Physiotherapy; Treatment of pain In the last 3 months with steroid injections; Treatment with acupuncture or surgery in the last 6 months; Central and peripheral nervous system diseases; Radial nerve entrapment; Inflammatory rheumatic diseases; Gout; radioulnar or radiohumeral osteoarthritis; A history of allergic reaction to corticosteroids

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain intensity. Timepoint: Two weeks after the intervention, eight weeks after intervention, 6 months after the intervention. Method of measurement: Using the VAS and the use of questionnaires quick-DASH score and PRTEE.;Functional status. Timepoint: Two weeks after the intervention, eight weeks after intervention, 6 months after the intervention. Method of measurement: the use of questionnaires quick-DASH score and PRTEE.	—

Measure

Time frame

Pain intensity. Timepoint: Two weeks after the intervention, eight weeks after intervention, 6 months after the intervention. Method of measurement: Using the VAS and the use of questionnaires quick-DASH score and PRTEE.;Functional status. Timepoint: Two weeks after the intervention, eight weeks after intervention, 6 months after the intervention. Method of measurement: the use of questionnaires quick-DASH score and PRTEE.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahmoud Abdullah

Medical School of Islamic Azad University of Shahroud

M.abdollahi@iau-shahrood.ac.ir+98 23 3239 4532

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026